Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Kamila Maliszewska-Olejniczak1, Karolina Pytlak2, Sandra Jaworowska1

  • 1Department of Physics and Biophysics, Institute of Biology, Warsaw University of Life Sciences - SGGW, Warsaw, Poland.

Molecular Oncology
|December 5, 2025
PubMed

Insights

Large-conductance calcium-activated potassium (BKCa) channels are crucial in brain function and glioblastoma. Targeting these channels, including mitochondrial BKCa (mitoBKCa), offers potential therapeutic strategies for brain tumors.

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • Large-conductance calcium-activated potassium (BKCa) channels regulate neuronal excitability and ion homeostasis in the brain.
  • BKCa channels are implicated in the pathogenesis of glioblastoma multiforme (GBM), a highly aggressive brain tumor.
  • Mitochondrial BKCa (mitoBKCa) channels influence tumor cell survival by modulating oxidative phosphorylation and reactive oxygen species.

Purpose of the Study:

  • To review the role of BKCa and mitoBKCa channels in glioblastoma biology.
  • To discuss the potential classification of BKCa channels as oncochannels.
  • To summarize emerging pharmacological strategies targeting BKCa channels for GBM treatment.

Main Methods:

  • Literature review of current research on BKCa channels in glioblastoma.
  • Analysis of the function of BKCa and mitoBKCa isoforms in tumor progression.
  • Examination of potential therapeutic targets and translational challenges.

Main Results:

  • Overexpression of BKCa channels, especially the gBKCa variant, enhances glioblastoma cell migration, invasion, and therapeutic resistance.
  • mitoBKCa channels promote glioblastoma cell survival under stress conditions.
  • BKCa channels are considered potential oncochannels due to their role in tumor progression.

Conclusions:

  • BKCa and mitoBKCa channels are critical players in glioblastoma pathogenesis and survival.
  • Targeting BKCa channels represents a promising therapeutic avenue for glioblastoma.
  • Translational challenges remain in developing effective BKCa-directed therapies for glioblastoma.